Pasithea Therapeutics Corp. - Common Stock - Nakit Akışı (NASDAQ:KTTA) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -3.17 M-14.56 M-13.43 M-13.92 M-15.21 M -16.94 M Yatırım faaliyetlerinden elde edilen nakit -21.5 K-2.06 M399.01 K011 K — Finansman faaliyetlerinden elde edilen nakit 55.93 M-3.21 M-3.73 M4.52 M63.52 M 62.05 M Serbest nakit akışı -3.17 M-14.56 M-14.43 M-13.92 M-15.21 M -16.94 M

Haberler

Pasithea, Kartik Krishnan’ı tıbbi direktör olarak atadı

Pasithea’nın NF1 ilaç adayına FDA’dan hızlı izleme statüsü

Pasithea Therapeutics Corp. (KTTA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript

Pasithea, MEK inhibitörü ilacı için klinik denemeler hakkında güncellemeler sundu

Pasithea provides updates on clinical trials for MEK inhibitor drug

Pasithea Therapeutics, Nasdaq’ın minimum teklif fiyatı kuralına uyumu yeniden sağladı

Pasithea Therapeutics regains Nasdaq compliance with minimum bid price rule

Pasithea Therapeutics stock initiated with Buy rating at H.C. Wainwright

Why Vision Marine Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - CEA Industries (NASDAQ:BNC), Aditxt (NASDAQ:ADTX)

Crude Oil Gains 1%; Tilray Brands Shares Plunge - Rich Sparkle Holdings (NASDAQ:ANPA), HeartBeam (NASDAQ:BEAT)

Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Anglogold Ashanti (NYSE:AU), HeartBeam (NASDAQ:BEAT)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.67%